263 related articles for article (PubMed ID: 15971207)
1. Increasing the molecular contacts between maurotoxin and Kv1.2 channel augments ligand affinity.
M'Barek S; Chagot B; Andreotti N; Visan V; Mansuelle P; Grissmer S; Marrakchi M; El Ayeb M; Sampieri F; Darbon H; Fajloun Z; De Waard M; Sabatier JM
Proteins; 2005 Aug; 60(3):401-11. PubMed ID: 15971207
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channels.
Blanc E; Sabatier JM; Kharrat R; Meunier S; el Ayeb M; Van Rietschoten J; Darbon H
Proteins; 1997 Nov; 29(3):321-33. PubMed ID: 9365987
[TBL] [Abstract][Full Text] [Related]
3. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the interacting surface of maurotoxin with the voltage-gated Shaker B K(+) channel.
Fajloun Z; Andreotti N; Fathallah M; Sabatier JM; De Waard M
J Pept Sci; 2011 Mar; 17(3):200-10. PubMed ID: 21308876
[TBL] [Abstract][Full Text] [Related]
5. Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels.
Fu W; Cui M; Briggs JM; Huang X; Xiong B; Zhang Y; Luo X; Shen J; Ji R; Jiang H; Chen K
Biophys J; 2002 Nov; 83(5):2370-85. PubMed ID: 12414674
[TBL] [Abstract][Full Text] [Related]
6. Blockage of human T lymphocyte Kv1.3 channels by Pi1, a novel class of scorpion toxin.
Péter M; Hajdu P; Varga Z; Damjanovich S; Possani LD; Panyi G; Gáspár R
Biochem Biophys Res Commun; 2000 Nov; 278(1):34-7. PubMed ID: 11071851
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, 3-D structure, and pharmacology of a reticulated chimeric peptide derived from maurotoxin and Tsk scorpion toxins.
Fajloun Z; Ferrat G; Carlier E; M'Barek S; Regaya I; Fathallah M; Rochat H; Darbon H; de Waard M; Sabatier JM
Biochem Biophys Res Commun; 2002 Mar; 291(3):640-8. PubMed ID: 11855838
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of inhibitory peptide maurotoxin recognizing Kv1.2 channel explored by ZDOCK and molecular dynamic simulations.
Yi H; Qiu S; Cao Z; Wu Y; Li W
Proteins; 2008 Feb; 70(3):844-54. PubMed ID: 17729277
[TBL] [Abstract][Full Text] [Related]
9. The investigation of interactions of kappa-Hefutoxin1 with the voltage-gated potassium channels: a computational simulation.
Zarrabi M; Naderi-Manesh H
Proteins; 2008 May; 71(3):1441-9. PubMed ID: 18076029
[TBL] [Abstract][Full Text] [Related]
10. The impact of the fourth disulfide bridge in scorpion toxins of the alpha-KTx6 subfamily.
Carrega L; Mosbah A; Ferrat G; Beeton C; Andreotti N; Mansuelle P; Darbon H; De Waard M; Sabatier JM
Proteins; 2005 Dec; 61(4):1010-23. PubMed ID: 16247791
[TBL] [Abstract][Full Text] [Related]
11. Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins.
Regaya I; Beeton C; Ferrat G; Andreotti N; Darbon H; De Waard M; Sabatier JM
J Biol Chem; 2004 Dec; 279(53):55690-6. PubMed ID: 15498765
[TBL] [Abstract][Full Text] [Related]
12. Maurotoxin and the Kv1.1 channel: voltage-dependent binding upon enantiomerization of the scorpion toxin disulfide bridge Cys31-Cys34.
Lecomte C; Ben Khalifa R; Martin-Eauclaire MF; Kharrat R; El Ayeb M; Darbon H; Rochat H; Crest M; Sabatier JM
J Pept Res; 2000 Mar; 55(3):246-54. PubMed ID: 10727107
[TBL] [Abstract][Full Text] [Related]
13. Disulfide bridge reorganization induced by proline mutations in maurotoxin.
Carlier E; Fajloun Z; Mansuelle P; Fathallah M; Mosbah A; Oughideni R; Sandoz G; Di Luccio E; Geib S; Regaya I; Brocard J; Rochat H; Darbon H; Devaux C; Sabatier JM; de Waard M
FEBS Lett; 2001 Feb; 489(2-3):202-7. PubMed ID: 11165250
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional consequences of the presence of a fourth disulfide bridge in the scorpion short toxins: solution structure of the potassium channel inhibitor HsTX1.
Savarin P; Romi-Lebrun R; Zinn-Justin S; Lebrun B; Nakajima T; Gilquin B; Menez A
Protein Sci; 1999 Dec; 8(12):2672-85. PubMed ID: 10631983
[TBL] [Abstract][Full Text] [Related]
15. Cobatoxin 1 from Centruroides noxius scorpion venom: chemical synthesis, three-dimensional structure in solution, pharmacology and docking on K+ channels.
Jouirou B; Mosbah A; Visan V; Grissmer S; M'Barek S; Fajloun Z; Van Rietschoten J; Devaux C; Rochat H; Lippens G; El Ayeb M; De Waard M; Mabrouk K; Sabatier JM
Biochem J; 2004 Jan; 377(Pt 1):37-49. PubMed ID: 14498829
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
17. Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins.
Pimentel C; M'Barek S; Visan V; Grissmer S; Sampieri F; Sabatier JM; Darbon H; Fajloun Z
Protein Sci; 2008 Jan; 17(1):107-18. PubMed ID: 18042681
[TBL] [Abstract][Full Text] [Related]
18. NMR solution structure of butantoxin.
Holaday SK; Martin BM; Fletcher PL; Krishna NR
Arch Biochem Biophys; 2000 Jul; 379(1):18-27. PubMed ID: 10864437
[TBL] [Abstract][Full Text] [Related]
19. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels.
Visan V; Fajloun Z; Sabatier JM; Grissmer S
Mol Pharmacol; 2004 Nov; 66(5):1103-12. PubMed ID: 15286210
[TBL] [Abstract][Full Text] [Related]
20. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
Papp F; Batista CV; Varga Z; Herceg M; Román-González SA; Gaspar R; Possani LD; Panyi G
Toxicon; 2009 Sep; 54(4):379-89. PubMed ID: 19500613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]